nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—UGT2B7—Mycophenolate mofetil—systemic lupus erythematosus	0.0677	0.0954	CbGbCtD
Ezetimibe—ABCC3—Cyclosporine—systemic lupus erythematosus	0.0594	0.0836	CbGbCtD
Ezetimibe—UGT1A1—Mycophenolate mofetil—systemic lupus erythematosus	0.0585	0.0824	CbGbCtD
Ezetimibe—ABCG2—Leflunomide—systemic lupus erythematosus	0.0521	0.0734	CbGbCtD
Ezetimibe—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.0405	0.0571	CbGbCtD
Ezetimibe—ABCC2—Mycophenolate mofetil—systemic lupus erythematosus	0.0356	0.0501	CbGbCtD
Ezetimibe—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0322	0.0453	CbGbCtD
Ezetimibe—ABCC3—Methotrexate—systemic lupus erythematosus	0.0314	0.0443	CbGbCtD
Ezetimibe—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0307	0.0432	CbGbCtD
Ezetimibe—ABCC2—Cyclosporine—systemic lupus erythematosus	0.027	0.038	CbGbCtD
Ezetimibe—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0258	0.0364	CbGbCtD
Ezetimibe—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0244	0.0344	CbGbCtD
Ezetimibe—ABCC2—Dexamethasone—systemic lupus erythematosus	0.0178	0.025	CbGbCtD
Ezetimibe—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.0163	0.0229	CbGbCtD
Ezetimibe—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0161	0.0226	CbGbCtD
Ezetimibe—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0153	0.0216	CbGbCtD
Ezetimibe—ABCC2—Methotrexate—systemic lupus erythematosus	0.0143	0.0201	CbGbCtD
Ezetimibe—ABCG2—Methotrexate—systemic lupus erythematosus	0.0129	0.0182	CbGbCtD
Ezetimibe—ABCG5—blood plasma—systemic lupus erythematosus	0.0126	0.161	CbGeAlD
Ezetimibe—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0116	0.0163	CbGbCtD
Ezetimibe—ABCG8—blood plasma—systemic lupus erythematosus	0.0112	0.143	CbGeAlD
Ezetimibe—ABCB1—Betamethasone—systemic lupus erythematosus	0.00996	0.014	CbGbCtD
Ezetimibe—ABCB1—Prednisolone—systemic lupus erythematosus	0.00983	0.0138	CbGbCtD
Ezetimibe—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00932	0.0131	CbGbCtD
Ezetimibe—ABCB1—Prednisone—systemic lupus erythematosus	0.00928	0.0131	CbGbCtD
Ezetimibe—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00918	0.0129	CbGbCtD
Ezetimibe—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0088	0.0124	CbGbCtD
Ezetimibe—CYP3A4—Dapsone—systemic lupus erythematosus	0.00802	0.0113	CbGbCtD
Ezetimibe—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00696	0.00979	CbGbCtD
Ezetimibe—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00696	0.00979	CbGbCtD
Ezetimibe—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00597	0.0084	CbGbCtD
Ezetimibe—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00589	0.00829	CbGbCtD
Ezetimibe—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00579	0.00816	CbGbCtD
Ezetimibe—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00558	0.00786	CbGbCtD
Ezetimibe—CYP3A4—Prednisone—systemic lupus erythematosus	0.00556	0.00783	CbGbCtD
Ezetimibe—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00527	0.00742	CbGbCtD
Ezetimibe—UGT1A1—urine—systemic lupus erythematosus	0.0047	0.0599	CbGeAlD
Ezetimibe—ABCB1—Methotrexate—systemic lupus erythematosus	0.00466	0.00656	CbGbCtD
Ezetimibe—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00347	0.00489	CbGbCtD
Ezetimibe—UGT1A1—blood plasma—systemic lupus erythematosus	0.00245	0.0312	CbGeAlD
Ezetimibe—SOAT1—connective tissue—systemic lupus erythematosus	0.00216	0.0275	CbGeAlD
Ezetimibe—SOAT1—nephron tubule—systemic lupus erythematosus	0.0021	0.0267	CbGeAlD
Ezetimibe—ANPEP—connective tissue—systemic lupus erythematosus	0.00207	0.0263	CbGeAlD
Ezetimibe—SLCO1B1—blood plasma—systemic lupus erythematosus	0.00204	0.026	CbGeAlD
Ezetimibe—ANPEP—nephron tubule—systemic lupus erythematosus	0.002	0.0255	CbGeAlD
Ezetimibe—ABCC3—blood plasma—systemic lupus erythematosus	0.00194	0.0247	CbGeAlD
Ezetimibe—ANPEP—skin of body—systemic lupus erythematosus	0.00187	0.0238	CbGeAlD
Ezetimibe—ANPEP—kidney—systemic lupus erythematosus	0.00176	0.0224	CbGeAlD
Ezetimibe—ANPEP—cortex of kidney—systemic lupus erythematosus	0.00172	0.0218	CbGeAlD
Ezetimibe—ANPEP—lymphoid tissue—systemic lupus erythematosus	0.00151	0.0193	CbGeAlD
Ezetimibe—CYP3A4—urine—systemic lupus erythematosus	0.00151	0.0192	CbGeAlD
Ezetimibe—SOAT1—tendon—systemic lupus erythematosus	0.00149	0.0189	CbGeAlD
Ezetimibe—SOAT1—bone marrow—systemic lupus erythematosus	0.00144	0.0183	CbGeAlD
Ezetimibe—ANPEP—tendon—systemic lupus erythematosus	0.00142	0.0181	CbGeAlD
Ezetimibe—ANPEP—bone marrow—systemic lupus erythematosus	0.00138	0.0175	CbGeAlD
Ezetimibe—UGT2B7—kidney—systemic lupus erythematosus	0.00131	0.0166	CbGeAlD
Ezetimibe—SOAT1—lung—systemic lupus erythematosus	0.0013	0.0166	CbGeAlD
Ezetimibe—ANPEP—lung—systemic lupus erythematosus	0.00125	0.0159	CbGeAlD
Ezetimibe—SOAT1—nervous system—systemic lupus erythematosus	0.00121	0.0154	CbGeAlD
Ezetimibe—SOAT1—central nervous system—systemic lupus erythematosus	0.00116	0.0148	CbGeAlD
Ezetimibe—ANPEP—nervous system—systemic lupus erythematosus	0.00116	0.0147	CbGeAlD
Ezetimibe—ANPEP—central nervous system—systemic lupus erythematosus	0.00111	0.0142	CbGeAlD
Ezetimibe—UGT1A1—kidney—systemic lupus erythematosus	0.00111	0.0142	CbGeAlD
Ezetimibe—SLCO1B1—kidney—systemic lupus erythematosus	0.000925	0.0118	CbGeAlD
Ezetimibe—ABCC3—kidney—systemic lupus erythematosus	0.000878	0.0112	CbGeAlD
Ezetimibe—ABCC2—nephron tubule—systemic lupus erythematosus	0.000798	0.0102	CbGeAlD
Ezetimibe—CYP3A4—blood plasma—systemic lupus erythematosus	0.000786	0.01	CbGeAlD
Ezetimibe—ABCC2—kidney—systemic lupus erythematosus	0.000701	0.00893	CbGeAlD
Ezetimibe—ABCC2—cortex of kidney—systemic lupus erythematosus	0.000683	0.0087	CbGeAlD
Ezetimibe—ABCC3—lung—systemic lupus erythematosus	0.000622	0.00792	CbGeAlD
Ezetimibe—ABCG2—nephron tubule—systemic lupus erythematosus	0.000582	0.00741	CbGeAlD
Ezetimibe—ABCC3—nervous system—systemic lupus erythematosus	0.000576	0.00733	CbGeAlD
Ezetimibe—ABCC2—tendon—systemic lupus erythematosus	0.000566	0.00721	CbGeAlD
Ezetimibe—ABCB1—blood plasma—systemic lupus erythematosus	0.000556	0.00709	CbGeAlD
Ezetimibe—ABCC3—central nervous system—systemic lupus erythematosus	0.000554	0.00706	CbGeAlD
Ezetimibe—ABCG2—bone marrow—systemic lupus erythematosus	0.0004	0.00509	CbGeAlD
Ezetimibe—ABCG2—lung—systemic lupus erythematosus	0.000362	0.00461	CbGeAlD
Ezetimibe—CYP3A4—kidney—systemic lupus erythematosus	0.000356	0.00454	CbGeAlD
Ezetimibe—ANPEP—C-MYB transcription factor network—PTGS2—systemic lupus erythematosus	0.000331	0.00622	CbGpPWpGaD
Ezetimibe—UGT1A1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000324	0.00608	CbGpPWpGaD
Ezetimibe—UGT2B7—Phase II conjugation—NAT2—systemic lupus erythematosus	0.000316	0.00594	CbGpPWpGaD
Ezetimibe—ABCC2—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000316	0.00593	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	0.000314	0.00589	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	0.000294	0.00551	CbGpPWpGaD
Ezetimibe—SLCO1B1—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000293	0.00551	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000292	0.00548	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	0.00029	0.00544	CbGpPWpGaD
Ezetimibe—ABCB1—nephron tubule—systemic lupus erythematosus	0.000287	0.00365	CbGeAlD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000282	0.0053	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.000276	0.00519	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—EP300—systemic lupus erythematosus	0.000275	0.00517	CbGpPWpGaD
Ezetimibe—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000272	0.00512	CbGpPWpGaD
Ezetimibe—SLCO1B1—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.00027	0.00507	CbGpPWpGaD
Ezetimibe—UGT1A1—Phase II conjugation—NAT2—systemic lupus erythematosus	0.000257	0.00483	CbGpPWpGaD
Ezetimibe—ABCB1—kidney—systemic lupus erythematosus	0.000252	0.00321	CbGeAlD
Ezetimibe—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000246	0.00313	CbGeAlD
Ezetimibe—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.00024	0.0045	CbGpPWpGaD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000236	0.00444	CbGpPWpGaD
Ezetimibe—CYP3A4—nervous system—systemic lupus erythematosus	0.000234	0.00298	CbGeAlD
Ezetimibe—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000232	0.00436	CbGpPWpGaD
Ezetimibe—UGT2B15—Biological oxidations—RXRA—systemic lupus erythematosus	0.000228	0.00428	CbGpPWpGaD
Ezetimibe—CYP3A4—central nervous system—systemic lupus erythematosus	0.000225	0.00287	CbGeAlD
Ezetimibe—ABCB1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000223	0.00419	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000218	0.0041	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000218	0.0041	CbGpPWpGaD
Ezetimibe—UGT1A3—Biological oxidations—NAT2—systemic lupus erythematosus	0.000218	0.00409	CbGpPWpGaD
Ezetimibe—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000217	0.00276	CbGeAlD
Ezetimibe—UGT1A3—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000215	0.00403	CbGpPWpGaD
Ezetimibe—ABCC3—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000206	0.00387	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.000205	0.00385	CbGpPWpGaD
Ezetimibe—ABCB1—bone marrow—systemic lupus erythematosus	0.000197	0.00251	CbGeAlD
Ezetimibe—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.00019	0.00357	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—NAT2—systemic lupus erythematosus	0.000185	0.00348	CbGpPWpGaD
Ezetimibe—UGT2B7—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000182	0.00343	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	0.000182	0.00341	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000179	0.00336	CbGpPWpGaD
Ezetimibe—ABCB1—lung—systemic lupus erythematosus	0.000179	0.00228	CbGeAlD
Ezetimibe—ABCB1—Allograft Rejection—C4A—systemic lupus erythematosus	0.00017	0.00319	CbGpPWpGaD
Ezetimibe—ABCB1—nervous system—systemic lupus erythematosus	0.000165	0.00211	CbGeAlD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	0.000165	0.0031	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—NAT2—systemic lupus erythematosus	0.000163	0.00306	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	0.000161	0.00303	CbGpPWpGaD
Ezetimibe—ABCB1—central nervous system—systemic lupus erythematosus	0.000159	0.00203	CbGeAlD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.000155	0.00292	CbGpPWpGaD
Ezetimibe—SLCO1B1—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000153	0.00288	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000153	0.00286	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—NAT2—systemic lupus erythematosus	0.00015	0.00282	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.000149	0.00281	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000149	0.0028	CbGpPWpGaD
Ezetimibe—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000148	0.00279	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000148	0.00279	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000148	0.00277	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	0.000147	0.00276	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—ACE—systemic lupus erythematosus	0.000146	0.00273	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	0.000145	0.00272	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000142	0.00267	CbGpPWpGaD
Ezetimibe—Rash—Leflunomide—systemic lupus erythematosus	0.000142	0.000897	CcSEcCtD
Ezetimibe—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000142	0.000896	CcSEcCtD
Ezetimibe—Mental disorder—Prednisone—systemic lupus erythematosus	0.000142	0.000896	CcSEcCtD
Ezetimibe—Nausea—Azathioprine—systemic lupus erythematosus	0.000141	0.000895	CcSEcCtD
Ezetimibe—Headache—Leflunomide—systemic lupus erythematosus	0.000141	0.000892	CcSEcCtD
Ezetimibe—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000141	0.000891	CcSEcCtD
Ezetimibe—Erythema—Prednisone—systemic lupus erythematosus	0.000141	0.00089	CcSEcCtD
Ezetimibe—Malnutrition—Prednisone—systemic lupus erythematosus	0.000141	0.00089	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000141	0.000889	CcSEcCtD
Ezetimibe—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.000883	CcSEcCtD
Ezetimibe—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00014	0.000883	CcSEcCtD
Ezetimibe—Hypertension—Betamethasone—systemic lupus erythematosus	0.000139	0.000882	CcSEcCtD
Ezetimibe—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000139	0.000882	CcSEcCtD
Ezetimibe—UGT1A3—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000139	0.00261	CbGpPWpGaD
Ezetimibe—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000139	0.00261	CbGpPWpGaD
Ezetimibe—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000139	0.000877	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000138	0.000876	CcSEcCtD
Ezetimibe—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000138	0.000873	CcSEcCtD
Ezetimibe—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000138	0.00087	CcSEcCtD
Ezetimibe—Myalgia—Betamethasone—systemic lupus erythematosus	0.000138	0.00087	CcSEcCtD
Ezetimibe—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000137	0.00258	CbGpPWpGaD
Ezetimibe—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000137	0.000868	CcSEcCtD
Ezetimibe—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000137	0.000868	CcSEcCtD
Ezetimibe—Discomfort—Betamethasone—systemic lupus erythematosus	0.000136	0.00086	CcSEcCtD
Ezetimibe—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000136	0.00086	CcSEcCtD
Ezetimibe—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000136	0.000859	CcSEcCtD
Ezetimibe—Pain—Prednisolone—systemic lupus erythematosus	0.000135	0.000855	CcSEcCtD
Ezetimibe—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000135	0.000854	CcSEcCtD
Ezetimibe—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000135	0.000851	CcSEcCtD
Ezetimibe—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000134	0.000849	CcSEcCtD
Ezetimibe—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000134	0.000848	CcSEcCtD
Ezetimibe—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.000847	CcSEcCtD
Ezetimibe—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.000847	CcSEcCtD
Ezetimibe—Nausea—Leflunomide—systemic lupus erythematosus	0.000134	0.000845	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000133	0.000843	CcSEcCtD
Ezetimibe—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000133	0.000842	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000132	0.000837	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000132	0.000836	CcSEcCtD
Ezetimibe—Pain—Hydrocortisone—systemic lupus erythematosus	0.000132	0.000835	CcSEcCtD
Ezetimibe—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000132	0.000834	CcSEcCtD
Ezetimibe—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000132	0.000834	CcSEcCtD
Ezetimibe—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000131	0.000831	CcSEcCtD
Ezetimibe—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000131	0.000829	CcSEcCtD
Ezetimibe—Infection—Betamethasone—systemic lupus erythematosus	0.000131	0.000829	CcSEcCtD
Ezetimibe—Infection—Dexamethasone—systemic lupus erythematosus	0.000131	0.000829	CcSEcCtD
Ezetimibe—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000131	0.000826	CcSEcCtD
Ezetimibe—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.00013	0.000825	CcSEcCtD
Ezetimibe—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.00013	0.000824	CcSEcCtD
Ezetimibe—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.00013	0.000823	CcSEcCtD
Ezetimibe—Anaemia—Prednisone—systemic lupus erythematosus	0.00013	0.000822	CcSEcCtD
Ezetimibe—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.00013	0.000819	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	0.000129	0.00243	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000129	0.000818	CcSEcCtD
Ezetimibe—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000129	0.000818	CcSEcCtD
Ezetimibe—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000129	0.000817	CcSEcCtD
Ezetimibe—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000129	0.000817	CcSEcCtD
Ezetimibe—Angioedema—Prednisone—systemic lupus erythematosus	0.000129	0.000813	CcSEcCtD
Ezetimibe—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000128	0.00241	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000128	0.000809	CcSEcCtD
Ezetimibe—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000128	0.000809	CcSEcCtD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000128	0.0024	CbGpPWpGaD
Ezetimibe—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000128	0.000808	CcSEcCtD
Ezetimibe—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000128	0.000807	CcSEcCtD
Ezetimibe—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000127	0.000804	CcSEcCtD
Ezetimibe—Malaise—Prednisone—systemic lupus erythematosus	0.000127	0.000802	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000126	0.000798	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	0.000126	0.00236	CbGpPWpGaD
Ezetimibe—Urticaria—Prednisolone—systemic lupus erythematosus	0.000126	0.000794	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	0.000125	0.00236	CbGpPWpGaD
Ezetimibe—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000125	0.000792	CcSEcCtD
Ezetimibe—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000125	0.000791	CcSEcCtD
Ezetimibe—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000125	0.000789	CcSEcCtD
Ezetimibe—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000125	0.000788	CcSEcCtD
Ezetimibe—Pain—Triamcinolone—systemic lupus erythematosus	0.000124	0.000786	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—NAT2—systemic lupus erythematosus	0.000123	0.00232	CbGpPWpGaD
Ezetimibe—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000123	0.000777	CcSEcCtD
Ezetimibe—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000123	0.000775	CcSEcCtD
Ezetimibe—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000123	0.000775	CcSEcCtD
Ezetimibe—UGT1A3—Biological oxidations—RXRA—systemic lupus erythematosus	0.000122	0.00229	CbGpPWpGaD
Ezetimibe—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000122	0.000772	CcSEcCtD
Ezetimibe—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000122	0.000772	CcSEcCtD
Ezetimibe—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000122	0.000772	CcSEcCtD
Ezetimibe—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000122	0.00077	CcSEcCtD
Ezetimibe—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000769	CcSEcCtD
Ezetimibe—Hypertension—Prednisone—systemic lupus erythematosus	0.000121	0.000768	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.00012	0.00076	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.00012	0.00076	CcSEcCtD
Ezetimibe—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00012	0.000758	CcSEcCtD
Ezetimibe—Arthralgia—Prednisone—systemic lupus erythematosus	0.00012	0.000758	CcSEcCtD
Ezetimibe—Myalgia—Prednisone—systemic lupus erythematosus	0.00012	0.000758	CcSEcCtD
Ezetimibe—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.00012	0.000757	CcSEcCtD
Ezetimibe—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000119	0.000756	CcSEcCtD
Ezetimibe—Alopecia—Methotrexate—systemic lupus erythematosus	0.000119	0.000755	CcSEcCtD
Ezetimibe—Insomnia—Betamethasone—systemic lupus erythematosus	0.000119	0.000754	CcSEcCtD
Ezetimibe—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000119	0.000754	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000119	0.000752	CcSEcCtD
Ezetimibe—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000119	0.000751	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—NAT2—systemic lupus erythematosus	0.000119	0.00223	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.000119	0.00223	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000119	0.00075	CcSEcCtD
Ezetimibe—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000118	0.000749	CcSEcCtD
Ezetimibe—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000118	0.000749	CcSEcCtD
Ezetimibe—Discomfort—Prednisone—systemic lupus erythematosus	0.000118	0.000749	CcSEcCtD
Ezetimibe—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000118	0.000748	CcSEcCtD
Ezetimibe—UGT2B7—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000118	0.00222	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000118	0.00222	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000118	0.00222	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000118	0.00221	CbGpPWpGaD
Ezetimibe—Erythema—Methotrexate—systemic lupus erythematosus	0.000118	0.000744	CcSEcCtD
Ezetimibe—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000118	0.000744	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	0.000117	0.00221	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000116	0.000736	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	0.000116	0.00218	CbGpPWpGaD
Ezetimibe—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000116	0.000734	CcSEcCtD
Ezetimibe—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000116	0.000734	CcSEcCtD
Ezetimibe—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000116	0.000733	CcSEcCtD
Ezetimibe—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000115	0.00073	CcSEcCtD
Ezetimibe—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000115	0.000729	CcSEcCtD
Ezetimibe—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000115	0.000727	CcSEcCtD
Ezetimibe—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000115	0.000726	CcSEcCtD
Ezetimibe—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000115	0.000726	CcSEcCtD
Ezetimibe—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000115	0.000725	CcSEcCtD
Ezetimibe—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000115	0.000725	CcSEcCtD
Ezetimibe—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000115	0.000725	CcSEcCtD
Ezetimibe—Infection—Prednisone—systemic lupus erythematosus	0.000114	0.000722	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	0.000114	0.00214	CbGpPWpGaD
Ezetimibe—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000114	0.00072	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000114	0.00072	CcSEcCtD
Ezetimibe—Back pain—Methotrexate—systemic lupus erythematosus	0.000114	0.000719	CcSEcCtD
Ezetimibe—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000114	0.000719	CcSEcCtD
Ezetimibe—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000114	0.000719	CcSEcCtD
Ezetimibe—Fatigue—Betamethasone—systemic lupus erythematosus	0.000114	0.000719	CcSEcCtD
Ezetimibe—Pain—Betamethasone—systemic lupus erythematosus	0.000113	0.000713	CcSEcCtD
Ezetimibe—Pain—Dexamethasone—systemic lupus erythematosus	0.000113	0.000713	CcSEcCtD
Ezetimibe—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000113	0.000712	CcSEcCtD
Ezetimibe—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000112	0.000709	CcSEcCtD
Ezetimibe—Skin disorder—Prednisone—systemic lupus erythematosus	0.000112	0.000705	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	0.000111	0.00209	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000111	0.00208	CbGpPWpGaD
Ezetimibe—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000111	0.0007	CcSEcCtD
Ezetimibe—Vomiting—Cyclosporine—systemic lupus erythematosus	0.00011	0.000698	CcSEcCtD
Ezetimibe—Rash—Cyclosporine—systemic lupus erythematosus	0.000109	0.000693	CcSEcCtD
Ezetimibe—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000109	0.000692	CcSEcCtD
Ezetimibe—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000109	0.000691	CcSEcCtD
Ezetimibe—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000109	0.00069	CcSEcCtD
Ezetimibe—Headache—Cyclosporine—systemic lupus erythematosus	0.000109	0.000688	CcSEcCtD
Ezetimibe—Anaemia—Methotrexate—systemic lupus erythematosus	0.000109	0.000687	CcSEcCtD
Ezetimibe—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000109	0.000687	CcSEcCtD
Ezetimibe—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000109	0.000687	CcSEcCtD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—EP300—systemic lupus erythematosus	0.000108	0.00203	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000108	0.000682	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000108	0.000682	CcSEcCtD
Ezetimibe—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000108	0.000681	CcSEcCtD
Ezetimibe—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000107	0.000677	CcSEcCtD
Ezetimibe—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000107	0.000676	CcSEcCtD
Ezetimibe—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000107	0.000676	CcSEcCtD
Ezetimibe—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000107	0.000675	CcSEcCtD
Ezetimibe—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.000671	CcSEcCtD
Ezetimibe—Malaise—Methotrexate—systemic lupus erythematosus	0.000106	0.000671	CcSEcCtD
Ezetimibe—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000106	0.000668	CcSEcCtD
Ezetimibe—Urticaria—Betamethasone—systemic lupus erythematosus	0.000105	0.000663	CcSEcCtD
Ezetimibe—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000105	0.000663	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000105	0.000662	CcSEcCtD
Ezetimibe—Dizziness—Prednisolone—systemic lupus erythematosus	0.000104	0.000661	CcSEcCtD
Ezetimibe—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000104	0.000659	CcSEcCtD
Ezetimibe—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000104	0.000659	CcSEcCtD
Ezetimibe—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000104	0.000659	CcSEcCtD
Ezetimibe—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000104	0.000659	CcSEcCtD
Ezetimibe—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000104	0.000659	CcSEcCtD
Ezetimibe—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000104	0.000658	CcSEcCtD
Ezetimibe—Insomnia—Prednisone—systemic lupus erythematosus	0.000104	0.000657	CcSEcCtD
Ezetimibe—UGT2B7—Biological oxidations—RXRA—systemic lupus erythematosus	0.000104	0.00195	CbGpPWpGaD
Ezetimibe—Nausea—Cyclosporine—systemic lupus erythematosus	0.000103	0.000652	CcSEcCtD
Ezetimibe—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000103	0.000652	CcSEcCtD
Ezetimibe—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000103	0.00065	CcSEcCtD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000103	0.00193	CbGpPWpGaD
Ezetimibe—Cough—Methotrexate—systemic lupus erythematosus	0.000103	0.000649	CcSEcCtD
Ezetimibe—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000103	0.000649	CcSEcCtD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—VEGFA—systemic lupus erythematosus	0.000102	0.00192	CbGpPWpGaD
Ezetimibe—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000102	0.000645	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	0.000102	0.00191	CbGpPWpGaD
Ezetimibe—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000101	0.000639	CcSEcCtD
Ezetimibe—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000101	0.000636	CcSEcCtD
Ezetimibe—Myalgia—Methotrexate—systemic lupus erythematosus	0.0001	0.000633	CcSEcCtD
Ezetimibe—Chest pain—Methotrexate—systemic lupus erythematosus	0.0001	0.000633	CcSEcCtD
Ezetimibe—Arthralgia—Methotrexate—systemic lupus erythematosus	0.0001	0.000633	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	0.0001	0.00188	CbGpPWpGaD
Ezetimibe—Decreased appetite—Prednisone—systemic lupus erythematosus	9.98e-05	0.000631	CcSEcCtD
Ezetimibe—Rash—Prednisolone—systemic lupus erythematosus	9.96e-05	0.00063	CcSEcCtD
Ezetimibe—Dermatitis—Prednisolone—systemic lupus erythematosus	9.95e-05	0.00063	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	9.94e-05	0.000629	CcSEcCtD
Ezetimibe—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	9.92e-05	0.000627	CcSEcCtD
Ezetimibe—Fatigue—Prednisone—systemic lupus erythematosus	9.9e-05	0.000626	CcSEcCtD
Ezetimibe—Headache—Prednisolone—systemic lupus erythematosus	9.9e-05	0.000626	CcSEcCtD
Ezetimibe—Discomfort—Methotrexate—systemic lupus erythematosus	9.89e-05	0.000626	CcSEcCtD
Ezetimibe—Constipation—Prednisone—systemic lupus erythematosus	9.82e-05	0.000621	CcSEcCtD
Ezetimibe—Vomiting—Hydrocortisone—systemic lupus erythematosus	9.81e-05	0.000621	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.8e-05	0.00184	CbGpPWpGaD
Ezetimibe—Rash—Hydrocortisone—systemic lupus erythematosus	9.73e-05	0.000615	CcSEcCtD
Ezetimibe—Dermatitis—Hydrocortisone—systemic lupus erythematosus	9.72e-05	0.000615	CcSEcCtD
Ezetimibe—Confusional state—Methotrexate—systemic lupus erythematosus	9.67e-05	0.000612	CcSEcCtD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	9.67e-05	0.00182	CbGpPWpGaD
Ezetimibe—Headache—Hydrocortisone—systemic lupus erythematosus	9.67e-05	0.000612	CcSEcCtD
Ezetimibe—UGT1A1—NRF2 pathway—RXRA—systemic lupus erythematosus	9.61e-05	0.0018	CbGpPWpGaD
Ezetimibe—Dizziness—Triamcinolone—systemic lupus erythematosus	9.61e-05	0.000608	CcSEcCtD
Ezetimibe—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	9.59e-05	0.000607	CcSEcCtD
Ezetimibe—Dizziness—Methylprednisolone—systemic lupus erythematosus	9.59e-05	0.000606	CcSEcCtD
Ezetimibe—Infection—Methotrexate—systemic lupus erythematosus	9.53e-05	0.000603	CcSEcCtD
Ezetimibe—Feeling abnormal—Prednisone—systemic lupus erythematosus	9.46e-05	0.000598	CcSEcCtD
Ezetimibe—Asthenia—Betamethasone—systemic lupus erythematosus	9.46e-05	0.000598	CcSEcCtD
Ezetimibe—Asthenia—Dexamethasone—systemic lupus erythematosus	9.46e-05	0.000598	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.44e-05	0.00177	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Methotrexate—systemic lupus erythematosus	9.41e-05	0.000595	CcSEcCtD
Ezetimibe—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	9.39e-05	0.000594	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	9.39e-05	0.000594	CcSEcCtD
Ezetimibe—Nausea—Prednisolone—systemic lupus erythematosus	9.38e-05	0.000594	CcSEcCtD
Ezetimibe—ABCC2—NRF2 pathway—RXRA—systemic lupus erythematosus	9.38e-05	0.00176	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	9.34e-05	0.00175	CbGpPWpGaD
Ezetimibe—Pruritus—Dexamethasone—systemic lupus erythematosus	9.33e-05	0.00059	CcSEcCtD
Ezetimibe—Pruritus—Betamethasone—systemic lupus erythematosus	9.33e-05	0.00059	CcSEcCtD
Ezetimibe—Skin disorder—Methotrexate—systemic lupus erythematosus	9.32e-05	0.00059	CcSEcCtD
Ezetimibe—Vomiting—Triamcinolone—systemic lupus erythematosus	9.24e-05	0.000584	CcSEcCtD
Ezetimibe—Vomiting—Methylprednisolone—systemic lupus erythematosus	9.22e-05	0.000583	CcSEcCtD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	9.19e-05	0.00173	CbGpPWpGaD
Ezetimibe—Nausea—Hydrocortisone—systemic lupus erythematosus	9.16e-05	0.00058	CcSEcCtD
Ezetimibe—Rash—Triamcinolone—systemic lupus erythematosus	9.16e-05	0.00058	CcSEcCtD
Ezetimibe—Dermatitis—Triamcinolone—systemic lupus erythematosus	9.15e-05	0.000579	CcSEcCtD
Ezetimibe—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	9.15e-05	0.00172	CbGpPWpGaD
Ezetimibe—Rash—Methylprednisolone—systemic lupus erythematosus	9.14e-05	0.000578	CcSEcCtD
Ezetimibe—Dermatitis—Methylprednisolone—systemic lupus erythematosus	9.13e-05	0.000578	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—RXRA—systemic lupus erythematosus	9.12e-05	0.00171	CbGpPWpGaD
Ezetimibe—Urticaria—Prednisone—systemic lupus erythematosus	9.12e-05	0.000577	CcSEcCtD
Ezetimibe—Headache—Triamcinolone—systemic lupus erythematosus	9.1e-05	0.000576	CcSEcCtD
Ezetimibe—Headache—Methylprednisolone—systemic lupus erythematosus	9.08e-05	0.000575	CcSEcCtD
Ezetimibe—Abdominal pain—Prednisone—systemic lupus erythematosus	9.08e-05	0.000574	CcSEcCtD
Ezetimibe—Body temperature increased—Prednisone—systemic lupus erythematosus	9.08e-05	0.000574	CcSEcCtD
Ezetimibe—Diarrhoea—Betamethasone—systemic lupus erythematosus	9.02e-05	0.000571	CcSEcCtD
Ezetimibe—Diarrhoea—Dexamethasone—systemic lupus erythematosus	9.02e-05	0.000571	CcSEcCtD
Ezetimibe—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	8.93e-05	0.00168	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.81e-05	0.00166	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	8.74e-05	0.000553	CcSEcCtD
Ezetimibe—Dizziness—Dexamethasone—systemic lupus erythematosus	8.72e-05	0.000551	CcSEcCtD
Ezetimibe—Dizziness—Betamethasone—systemic lupus erythematosus	8.72e-05	0.000551	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	8.69e-05	0.00163	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	8.68e-05	0.00163	CbGpPWpGaD
Ezetimibe—Insomnia—Methotrexate—systemic lupus erythematosus	8.68e-05	0.000549	CcSEcCtD
Ezetimibe—Nausea—Triamcinolone—systemic lupus erythematosus	8.63e-05	0.000546	CcSEcCtD
Ezetimibe—Paraesthesia—Methotrexate—systemic lupus erythematosus	8.62e-05	0.000545	CcSEcCtD
Ezetimibe—Nausea—Methylprednisolone—systemic lupus erythematosus	8.61e-05	0.000545	CcSEcCtD
Ezetimibe—Dyspnoea—Methotrexate—systemic lupus erythematosus	8.55e-05	0.000541	CcSEcCtD
Ezetimibe—ANPEP—Metabolism of proteins—F2—systemic lupus erythematosus	8.53e-05	0.0016	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.48e-05	0.00159	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.46e-05	0.00159	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Prednisone—systemic lupus erythematosus	8.46e-05	0.000535	CcSEcCtD
Ezetimibe—Dyspepsia—Methotrexate—systemic lupus erythematosus	8.45e-05	0.000534	CcSEcCtD
Ezetimibe—UGT1A1—Biological oxidations—RXRA—systemic lupus erythematosus	8.43e-05	0.00158	CbGpPWpGaD
Ezetimibe—Vomiting—Betamethasone—systemic lupus erythematosus	8.38e-05	0.00053	CcSEcCtD
Ezetimibe—Vomiting—Dexamethasone—systemic lupus erythematosus	8.38e-05	0.00053	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.38e-05	0.00157	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	8.38e-05	0.00157	CbGpPWpGaD
Ezetimibe—Decreased appetite—Methotrexate—systemic lupus erythematosus	8.34e-05	0.000528	CcSEcCtD
Ezetimibe—Rash—Betamethasone—systemic lupus erythematosus	8.31e-05	0.000526	CcSEcCtD
Ezetimibe—Rash—Dexamethasone—systemic lupus erythematosus	8.31e-05	0.000526	CcSEcCtD
Ezetimibe—Dermatitis—Betamethasone—systemic lupus erythematosus	8.3e-05	0.000525	CcSEcCtD
Ezetimibe—Dermatitis—Dexamethasone—systemic lupus erythematosus	8.3e-05	0.000525	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	8.28e-05	0.000524	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	8.28e-05	0.00156	CbGpPWpGaD
Ezetimibe—Fatigue—Methotrexate—systemic lupus erythematosus	8.27e-05	0.000523	CcSEcCtD
Ezetimibe—Headache—Betamethasone—systemic lupus erythematosus	8.26e-05	0.000522	CcSEcCtD
Ezetimibe—Headache—Dexamethasone—systemic lupus erythematosus	8.26e-05	0.000522	CcSEcCtD
Ezetimibe—Asthenia—Prednisone—systemic lupus erythematosus	8.24e-05	0.000521	CcSEcCtD
Ezetimibe—Pain—Methotrexate—systemic lupus erythematosus	8.2e-05	0.000519	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	8.16e-05	0.00153	CbGpPWpGaD
Ezetimibe—Pruritus—Prednisone—systemic lupus erythematosus	8.12e-05	0.000514	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	8.12e-05	0.00152	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.07e-05	0.00152	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Methotrexate—systemic lupus erythematosus	7.91e-05	0.0005	CcSEcCtD
Ezetimibe—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	7.89e-05	0.00148	CbGpPWpGaD
Ezetimibe—Diarrhoea—Prednisone—systemic lupus erythematosus	7.85e-05	0.000497	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	7.85e-05	0.000496	CcSEcCtD
Ezetimibe—Nausea—Dexamethasone—systemic lupus erythematosus	7.83e-05	0.000495	CcSEcCtD
Ezetimibe—Nausea—Betamethasone—systemic lupus erythematosus	7.83e-05	0.000495	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.71e-05	0.00145	CbGpPWpGaD
Ezetimibe—Urticaria—Methotrexate—systemic lupus erythematosus	7.62e-05	0.000482	CcSEcCtD
Ezetimibe—ANPEP—Metabolism of proteins—CCL2—systemic lupus erythematosus	7.6e-05	0.00143	CbGpPWpGaD
Ezetimibe—Dizziness—Prednisone—systemic lupus erythematosus	7.59e-05	0.00048	CcSEcCtD
Ezetimibe—Body temperature increased—Methotrexate—systemic lupus erythematosus	7.58e-05	0.00048	CcSEcCtD
Ezetimibe—Abdominal pain—Methotrexate—systemic lupus erythematosus	7.58e-05	0.00048	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.42e-05	0.00139	CbGpPWpGaD
Ezetimibe—Vomiting—Prednisone—systemic lupus erythematosus	7.3e-05	0.000462	CcSEcCtD
Ezetimibe—Rash—Prednisone—systemic lupus erythematosus	7.24e-05	0.000458	CcSEcCtD
Ezetimibe—Dermatitis—Prednisone—systemic lupus erythematosus	7.23e-05	0.000458	CcSEcCtD
Ezetimibe—Headache—Prednisone—systemic lupus erythematosus	7.19e-05	0.000455	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	7.19e-05	0.00135	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Methotrexate—systemic lupus erythematosus	7.07e-05	0.000447	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—NAT2—systemic lupus erythematosus	6.95e-05	0.0013	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—RXRA—systemic lupus erythematosus	6.91e-05	0.0013	CbGpPWpGaD
Ezetimibe—Asthenia—Methotrexate—systemic lupus erythematosus	6.88e-05	0.000435	CcSEcCtD
Ezetimibe—Nausea—Prednisone—systemic lupus erythematosus	6.82e-05	0.000431	CcSEcCtD
Ezetimibe—Pruritus—Methotrexate—systemic lupus erythematosus	6.79e-05	0.000429	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	6.72e-05	0.00126	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—RXRA—systemic lupus erythematosus	6.66e-05	0.00125	CbGpPWpGaD
Ezetimibe—Diarrhoea—Methotrexate—systemic lupus erythematosus	6.56e-05	0.000415	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.41e-05	0.0012	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	6.36e-05	0.00119	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	6.35e-05	0.00119	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	6.35e-05	0.00119	CbGpPWpGaD
Ezetimibe—Dizziness—Methotrexate—systemic lupus erythematosus	6.34e-05	0.000401	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	6.18e-05	0.00116	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.17e-05	0.00116	CbGpPWpGaD
Ezetimibe—Vomiting—Methotrexate—systemic lupus erythematosus	6.1e-05	0.000386	CcSEcCtD
Ezetimibe—Rash—Methotrexate—systemic lupus erythematosus	6.05e-05	0.000383	CcSEcCtD
Ezetimibe—Dermatitis—Methotrexate—systemic lupus erythematosus	6.04e-05	0.000382	CcSEcCtD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	6.02e-05	0.00113	CbGpPWpGaD
Ezetimibe—Headache—Methotrexate—systemic lupus erythematosus	6.01e-05	0.00038	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	5.9e-05	0.00111	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PPARG—systemic lupus erythematosus	5.76e-05	0.00108	CbGpPWpGaD
Ezetimibe—Nausea—Methotrexate—systemic lupus erythematosus	5.7e-05	0.000361	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	5.69e-05	0.00107	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	5.66e-05	0.00106	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	5.61e-05	0.00105	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	5.55e-05	0.00104	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.53e-05	0.00104	CbGpPWpGaD
Ezetimibe—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.5e-05	0.00103	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ALB—systemic lupus erythematosus	5.18e-05	0.000973	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	5.11e-05	0.00096	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—TGFB1—systemic lupus erythematosus	4.99e-05	0.000938	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	4.97e-05	0.000933	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—NOS3—systemic lupus erythematosus	4.95e-05	0.000931	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	4.72e-05	0.000887	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTGS2—systemic lupus erythematosus	4.53e-05	0.000851	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.48e-05	0.000842	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PPARG—systemic lupus erythematosus	4.37e-05	0.00082	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.3e-05	0.000808	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	4.25e-05	0.000798	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—TGFB1—systemic lupus erythematosus	4.25e-05	0.000798	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—TGFB1—systemic lupus erythematosus	4.25e-05	0.000798	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PPARG—systemic lupus erythematosus	4.2e-05	0.000789	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.19e-05	0.000787	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	4.06e-05	0.000762	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.98e-05	0.000748	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ALB—systemic lupus erythematosus	3.93e-05	0.000737	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—RXRA—systemic lupus erythematosus	3.89e-05	0.000732	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.79e-05	0.000711	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ALB—systemic lupus erythematosus	3.78e-05	0.00071	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—EP300—systemic lupus erythematosus	3.77e-05	0.000708	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—NOS3—systemic lupus erythematosus	3.76e-05	0.000705	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	3.73e-05	0.000701	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NAT2—systemic lupus erythematosus	3.72e-05	0.000699	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—NOS3—systemic lupus erythematosus	3.61e-05	0.000679	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.56e-05	0.000668	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—TGFB1—systemic lupus erythematosus	3.45e-05	0.000648	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	3.44e-05	0.000646	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTGS2—systemic lupus erythematosus	3.43e-05	0.000645	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—TGFB1—systemic lupus erythematosus	3.37e-05	0.000632	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	3.32e-05	0.000623	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTGS2—systemic lupus erythematosus	3.31e-05	0.000621	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	3.26e-05	0.000611	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NAT2—systemic lupus erythematosus	3.16e-05	0.000594	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NAT2—systemic lupus erythematosus	3.16e-05	0.000594	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	3.15e-05	0.000592	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3e-05	0.000564	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.97e-05	0.000557	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.91e-05	0.000547	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—EP300—systemic lupus erythematosus	2.86e-05	0.000537	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.82e-05	0.00053	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	2.82e-05	0.00053	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.81e-05	0.000527	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—EP300—systemic lupus erythematosus	2.75e-05	0.000516	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.61e-05	0.00049	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	2.59e-05	0.000486	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NAT2—systemic lupus erythematosus	2.57e-05	0.000483	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.51e-05	0.000472	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PPARG—systemic lupus erythematosus	2.46e-05	0.000462	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	2.42e-05	0.000454	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	2.38e-05	0.000447	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NAT2—systemic lupus erythematosus	2.36e-05	0.000443	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.26e-05	0.000425	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ALB—systemic lupus erythematosus	2.21e-05	0.000415	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	2.18e-05	0.00041	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.15e-05	0.000404	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—NOS3—systemic lupus erythematosus	2.12e-05	0.000397	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—RXRA—systemic lupus erythematosus	2.09e-05	0.000392	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.98e-05	0.000372	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—systemic lupus erythematosus	1.93e-05	0.000363	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.87e-05	0.000352	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—RXRA—systemic lupus erythematosus	1.77e-05	0.000333	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—RXRA—systemic lupus erythematosus	1.77e-05	0.000333	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.77e-05	0.000332	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.7e-05	0.00032	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.68e-05	0.000316	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.67e-05	0.000314	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.65e-05	0.000309	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—EP300—systemic lupus erythematosus	1.61e-05	0.000302	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.6e-05	0.000301	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.54e-05	0.00029	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.48e-05	0.000278	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.47e-05	0.000277	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.47e-05	0.000276	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—RXRA—systemic lupus erythematosus	1.44e-05	0.000271	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.41e-05	0.000265	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.39e-05	0.000261	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	1.32e-05	0.000248	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PPARG—systemic lupus erythematosus	1.32e-05	0.000247	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.28e-05	0.00024	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.23e-05	0.00023	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	1.22e-05	0.00023	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.19e-05	0.000224	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—systemic lupus erythematosus	1.18e-05	0.000222	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.18e-05	0.000222	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NOS3—systemic lupus erythematosus	1.13e-05	0.000213	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PPARG—systemic lupus erythematosus	1.12e-05	0.00021	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPARG—systemic lupus erythematosus	1.12e-05	0.00021	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—systemic lupus erythematosus	1.04e-05	0.000195	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—systemic lupus erythematosus	1.01e-05	0.000189	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—systemic lupus erythematosus	1.01e-05	0.000189	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NOS3—systemic lupus erythematosus	9.63e-06	0.000181	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NOS3—systemic lupus erythematosus	9.63e-06	0.000181	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARG—systemic lupus erythematosus	9.1e-06	0.000171	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—systemic lupus erythematosus	8.81e-06	0.000165	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—systemic lupus erythematosus	8.81e-06	0.000165	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—EP300—systemic lupus erythematosus	8.62e-06	0.000162	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	8.34e-06	0.000157	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—systemic lupus erythematosus	8.18e-06	0.000154	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.02e-06	0.000151	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NOS3—systemic lupus erythematosus	7.83e-06	0.000147	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	7.72e-06	0.000145	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	7.5e-06	0.000141	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—EP300—systemic lupus erythematosus	7.33e-06	0.000138	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—EP300—systemic lupus erythematosus	7.33e-06	0.000138	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	7.27e-06	0.000137	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	7.17e-06	0.000135	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—systemic lupus erythematosus	7.16e-06	0.000134	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—systemic lupus erythematosus	6.94e-06	0.00013	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	6.64e-06	0.000125	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	6.61e-06	0.000124	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	6.56e-06	0.000123	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	6.07e-06	0.000114	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—EP300—systemic lupus erythematosus	5.95e-06	0.000112	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	5.46e-06	0.000102	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—EP300—systemic lupus erythematosus	5.05e-06	9.49e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	4.18e-06	7.84e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	4.07e-06	7.65e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.75e-06	7.05e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	3.59e-06	6.75e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	3.28e-06	6.17e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.73e-06	5.13e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.57e-06	4.83e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.31e-06	4.34e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.21e-06	4.16e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.02e-06	3.8e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.68e-06	3.16e-05	CbGpPWpGaD
